iLIVER

ISSN 2772-9478 CN 10-1764/R
Editor-in-Chief: Jiahong Dong
Open Access
Journal Home > Previous Issue
Previous Issue
Volume 1
Issue 1, March 2022
pp.1-80 12 articles
Open Access Editorial
Prometheus' revelation: Deciphering the mysteries of the liver, towards a shared healthful future
https://doi.org/10.1016/j.iliver.2022.04.001
Published: 12 April 2022
2022, 1 (1): 1-2
Downloads: 22 | Views: 420 | PDF (211 KB)
Open Access Review
Liver transplantation for malignant liver tumors
https://doi.org/10.1016/j.iliver.2022.04.002
Published: 18 April 2022
2022, 1 (1): 3-11
Downloads: 36 | Views: 685 | PDF (1.2 MB)
Open Access Review
Perihilar cholangiocarcinoma: a surgeon's perspective
https://doi.org/10.1016/j.iliver.2022.03.004
Published: 05 April 2022
2022, 1 (1): 12-24
Downloads: 125 | Views: 1155 | PDF (2.7 MB)
Open Access Original Article
Associating liver partition and portal vein ligation for staged hepatectomy ​for colorectal liver metastasis: a single-center experience
https://doi.org/10.1016/j.iliver.2022.02.002
Published: 09 March 2022
2022, 1 (1): 25-29
Downloads: 27 | Views: 587 | PDF (306.1 KB)
Open Access Original Article
Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?
https://doi.org/10.1016/j.iliver.2022.02.001
Published: 07 March 2022
2022, 1 (1): 30-34
Downloads: 43 | Views: 2048 | PDF (445.2 KB)
Open Access Original Article
Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma
https://doi.org/10.1016/j.iliver.2022.01.001
Published: 07 March 2022
2022, 1 (1): 35-42
Downloads: 57 | Views: 941 | PDF (850.9 KB)
Open Access Review
Application of immune checkpoint inhibitors in hepatobiliary cancers
https://doi.org/10.1016/j.iliver.2022.03.002
Published: 17 March 2022
2022, 1 (1): 43-48
Downloads: 11 | Views: 725 | PDF (304 KB)
Open Access Review
Advances in artificial intelligence techniques drive the application of radiomics in the clinical research of hepatocellular carcinoma
https://doi.org/10.1016/j.iliver.2022.02.005
Published: 10 March 2022
2022, 1 (1): 49-54
Downloads: 23 | Views: 680 | PDF (353.8 KB)
Open Access Review
Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment?
https://doi.org/10.1016/j.iliver.2022.03.003
Published: 28 March 2022
2022, 1 (1): 55-64
Downloads: 32 | Views: 704 | PDF (1.6 MB)
Open Access Review
The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease
https://doi.org/10.1016/j.iliver.2022.02.004
Published: 10 March 2022
2022, 1 (1): 65-71
Downloads: 131 | Views: 886 | PDF (600.6 KB)
Open Access Short Communication
Ascorbic acid ameliorates isoniazid-rifampicin-induced hepatocellular damage in rats
https://doi.org/10.1016/j.iliver.2022.03.001
Published: 10 March 2022
2022, 1 (1): 72-77
Downloads: 26 | Views: 637 | PDF (720.7 KB)
Open Access Short Communication
Tumor-immune Co-evolution in hepatocellular carcinoma and its implication for immunotherapy resistance
https://doi.org/10.1016/j.iliver.2022.02.003
Published: 09 March 2022
2022, 1 (1): 78-80
Downloads: 228 | Views: 893 | PDF (249.2 KB)